InvestSMART

Artrya Limited (ASX: AYA) - Announcements

Current share price for AYA : $5.640 0.11 (1.91%)+

ASX company news and announcements for Artrya Limited (AYA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Artrya Limited (AYA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Artrya Limited (AYA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Artrya Limited (AYA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$919 Change in substantial holding 26 Aug 2025 4:46PM $2.010 $5.640 risen by 180.60%
$919 Application for quotation of securities - AYA 25 Aug 2025 5:00PM $2.100 $5.640 risen by 168.57%
$919 Issue of Shares on Exercise of Options 25 Aug 2025 4:54PM $2.100 $5.640 risen by 168.57%
$919 SAPPHIRE Study Update - Piedmont Healthcare to participate 25 Aug 2025 8:57AM $2.000 $5.640 risen by 182%
$919 Notification regarding unquoted securities - AYA 21 Aug 2025 6:04PM $1.790 $5.640 risen by 215.08%
$919 Application for quotation of securities - AYA 21 Aug 2025 5:58PM $1.790 $5.640 risen by 215.08%
$919 Issue of Securities 21 Aug 2025 5:53PM $1.790 $5.640 risen by 215.08%
$919 FDA clearance of Salix Coronary Plaque module 21 Aug 2025 8:29AM $1.300 $5.640 risen by 333.85%
$919 Appendix 4E and Annual Financial Statements 20 Aug 2025 7:06PM $1.300 $5.640 risen by 333.85%
$919 Presentation - 19th Annual Bioshares Investor Conference 8 Aug 2025 8:29AM $1.120 $5.640 risen by 403.57%
$919 Application for quotation of securities - AYA 4 Aug 2025 5:24PM $0.990 $5.640 risen by 469.70%
$919 Application for quotation of securities - AYA 28 Jul 2025 4:53PM $0.975 $5.640 risen by 478.46%
$919 Quarterly Activities/Appendix 4C Cash Flow Report 28 Jul 2025 8:50AM $1.030 $5.640 risen by 447.57%
$919 Application for quotation of securities - AYA 21 Jul 2025 4:28PM $1.100 $5.640 risen by 412.73%
$919 Application for quotation of securities - AYA 14 Jul 2025 5:48PM $0.925 $5.640 risen by 509.73%
$919 AYA Signs US$0.6m Five Year Contract with Tanner Health 10 Jul 2025 8:55AM $0.915 $5.640 risen by 516.39%
$919 Notification of cessation of securities - AYA 3 Jul 2025 4:54PM $0.800 $5.640 risen by 605%
$919 Notification of cessation of securities - AYA 1 Jul 2025 5:02PM $0.700 $5.640 risen by 705.71%
$919 Application for quotation of securities - AYA 1 Jul 2025 4:58PM $0.700 $5.640 risen by 705.71%
$919 Issue of Shares on Exercise of Options 1 Jul 2025 4:53PM $0.700 $5.640 risen by 705.71%
$919 Artrya Leadership Transition 1 Jul 2025 9:06AM $0.720 $5.640 risen by 683.33%
$919 Application for quotation of securities - AYA 20 Jun 2025 5:38PM $0.630 $5.640 risen by 795.24%
$919 Issue of Shares on Exercise of Incentive Securities 20 Jun 2025 5:34PM $0.630 $5.640 risen by 795.24%
$919 Artrya Submits FDA Application - Coronary Plaque Module 16 Jun 2025 8:48AM $0.720 $5.640 risen by 683.33%
$919 Application for quotation of securities - AYA 26 May 2025 7:09PM $0.760 $5.640 risen by 642.11%

101 - 125 of 502 results

Page 5 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.